Compare, Analyse Divis Laboratories with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ACTAVIS (US) - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   ACTAVIS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
ACTAVIS
Dec-18
DIVIS LABORATORIES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,63913,729-   
Low Rs1,1159,209-   
Sales per share (Unadj.) Rs186.33,367.7-  
Earnings per share (Unadj.) Rs51.0-1,084.7-  
Cash flow per share (Unadj.) Rs57.3354.9-  
Dividends per share (Unadj.) Rs16.000-  
Dividend yield (eoy) %1.20-  
Book value per share (Unadj.) Rs261.813,890.1-  
Shares outstanding (eoy) m265.47332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.43.4 217.0%   
Avg P/E ratio x27.0-10.6 -255.6%  
P/CF ratio (eoy) x24.032.3 74.3%  
Price / Book Value ratio x5.30.8 637.1%  
Dividend payout %31.40-   
Avg Mkt Cap Rs m365,5923,814,612 9.6%   
No. of employees `00011.816.9 70.1%   
Total wages/salary Rs m5,4230-   
Avg. sales/employee Rs Th4,175.166,277.4 6.3%   
Avg. wages/employee Rs Th457.70-   
Avg. net profit/employee Rs Th1,141.8-21,348.0 -5.3%   
INCOME DATA
Net Sales Rs m49,4631,120,088 4.4%  
Other income Rs m1,55621,420 7.3%   
Total revenues Rs m51,0191,141,507 4.5%   
Gross profit Rs m18,71829,352 63.8%  
Depreciation Rs m1,689478,813 0.4%   
Interest Rs m3564,635 0.1%   
Profit before tax Rs m18,551-492,677 -3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m5,023-6,244 -80.5%   
Profit after tax Rs m13,527-360,781 -3.7%  
Gross profit margin %37.82.6 1,444.1%  
Effective tax rate %27.11.3 2,136.8%   
Net profit margin %27.3-32.2 -84.9%  
BALANCE SHEET DATA
Current assets Rs m46,501459,401 10.1%   
Current liabilities Rs m8,468406,402 2.1%   
Net working cap to sales %76.94.7 1,625.0%  
Current ratio x5.51.1 485.8%  
Inventory Days Days13120 667.9%  
Debtors Days Days8666 129.5%  
Net fixed assets Rs m25,797126,788 20.3%   
Share capital Rs m5310-   
"Free" reserves Rs m68,9620-   
Net worth Rs m69,4934,619,838 1.5%   
Long term debt Rs m01,626,813 0.0%   
Total assets Rs m80,3837,221,859 1.1%  
Interest coverage x531.0-6.6 -8,018.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.2 396.7%   
Return on assets %16.9-4.1 -411.5%  
Return on equity %19.5-7.8 -249.3%  
Return on capital %26.7-4.8 -552.5%  
Exports to sales %00-   
Imports to sales %24.60-   
Net fx Rs m28,8330-   
CASH FLOW
From Operations Rs m9,543400,165 2.4%  
From Investments Rs m-6,854219,839 -3.1%  
From Financial Activity Rs m-2,459-686,803 0.4%  
Net Cashflow Rs m230-66,466 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare DIVIS LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DIVIS LABORATORIES With: SUVEN LIFESCIENCES  ORCHID PHARMA LTD  IPCA LABS  PLETHICO PHARMA  VENUS REMEDIES  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Oct 23, 2019 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS